Results 121 to 130 of about 426,014 (383)
Scientific Reports, 2016 Hemolytic anemia intensity has been suggested as a vital factor for the growth of certain clinical complications of sickle cell disease. However, there is no effective and rapid diagnostic method.
S. Sang +7 more
semanticscholar +1 more source
Porto‐sinusoidal vascular disorder in a pediatric patient with prolidase deficiency: A case report
JPGN Reports, EarlyView.Abstract Prolidase deficiency (PD) is a rare autosomal recessive disorder affecting collagen turnover, leading to diverse clinical manifestations including dermatologic lesions, hepatosplenomegaly, and vascular anomalies. Liver involvement in PD is poorly understood, with few reported cases.
Melissa Castro +5 more
wiley +1 more source
JPGN Reports, EarlyView.ABSTRACT Sickle cell anemia (SCA) is a genetic disorder that presents with a variety of systemic complications, including gastrointestinal (GI) manifestations. These GI symptoms can overlap with those of digestive autoimmune diseases (DAD) such as inflammatory bowel disease (IBD) and autoimmune hepatitis (AIH), complicating the diagnosis and management.
Saray Mesonero Cavia +3 more
wiley +1 more source
Autoimmune Hemolytic Anemia as a Complication of Nivolumab Therapy
Case Reports in Oncology, 2016 Recently, immunotherapeutic drugs, including PD-1 inhibitors (nivolumab, pembrolizumab), PD-L1 inhibitors (atezolizumab, avelumab), and CTLA4 inhibitors (ipiliumumab), have emerged as important additions to the armamentarium against certain malignancies ...
Amruth R. Palla +3 more
semanticscholar +1 more source
Refractory anaemia in a patient with end‐stage heart failure secondary to aortic stenosis
ESC Heart Failure, EarlyView.
Jiayu Liang, Suxin Luo, Bi Huang
wiley +1 more source
Hemolytic Anemia and Reactive Thrombocytosis Associated With Cefoperazone/Sulbactam
Frontiers in Pharmacology, 2019 Background: Cefoperazone/sulbactam is a broad-spectrum antibacterial agent. Drug-induced immune hemolytic anemia is a rare but serious condition, and reactive thrombocytosis is caused by processes extrinsic to the megakaryocyte.
Ling Zhou, Jianan Bao, Jingjing Ma
doaj +1 more source
A rare case of renal thrombotic microangiopathy associated with Castleman’s disease [PDF]
, 2017 BACKGROUND: Castleman’s disease (CD) is an uncommon, heterogeneous lympho-proliferative disorder leading to high circulating levels of interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF).
Chen, Ying Maggie +3 more
core +2 more sources
New Insights in the Pathogenesis of Autoimmune Hemolytic Anemia
Transfusion Medicine and Hemotherapy, 2015 Autoimmune hemolytic anemia (AIHA) is caused by the increased destruction of red blood cells (RBCs) by anti-RBC autoantibodies with or without complement activation.
W. Barcellini
semanticscholar +1 more source
Med Research, EarlyView.ABSTRACT The use of immune checkpoint inhibitors (ICIs) has significantly improved the efficacy of cancer therapy, but their associated immune‐related adverse events (irAEs) can severely compromise treatment safety. This review systematically summarizes the core mechanisms underlying irAEs, which include multi‐organ damage resulting from T‐cell ...
Anqi Lin +8 more
wiley +1 more source
Reactions of hemoglobin with phenylhydrazine: a review of selected aspects. [PDF]
, 1985 It is well known that phenylhydrazine induces hemolytic anemia. This is thought to result from the reaction of phenylhydrazine with hemoglobin. The accompanying oxidation of phenylhydrazine leads to the formation of a number of products, including ...
Hill, HA, Shetlar, MD
core +2 more sources